ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - January 1920

Decade

Year

Issue

September 2024, Vol 160, No. 9, Pages 911-1015

Editorial

Extending Maintenance Dosing Intervals for Guselkumab in the Treatment of Patients With Psoriasis

Abstract Full Text
JAMA Dermatol. 2024;160(9):919-920. doi:10.1001/jamadermatol.2024.2462

Advancing Research in Cutaneous Squamous Cell Carcinoma—Precision Management Requires Precision Data

Abstract Full Text
JAMA Dermatol. 2024;160(9):920-922. doi:10.1001/jamadermatol.2024.2235

Does the Germline Genome Encode for the Invasiveness of a Cutaneous Melanoma?

Abstract Full Text
JAMA Dermatol. 2024;160(9):922-924. doi:10.1001/jamadermatol.2024.2599
Original Investigation

Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation

Abstract Full Text
JAMA Dermatol. 2024;160(9):927-935. doi:10.1001/jamadermatol.2024.2056

This multinational cohort study investigates the length of time in which patients take omalizumab and the reasons and potential predictors for its discontinuation.

Systemic Immunomodulatory Treatments for Atopic Dermatitis: Living Systematic Review and Network Meta-Analysis Update

Abstract Full Text
open access
JAMA Dermatol. 2024;160(9):936-944. doi:10.1001/jamadermatol.2024.2192

This update of a living systematic review and network meta-analysis compares the efficacy and safety of systemic treatments for atopic dermatitis, including lebrikizumab.

Immune-Mediated and Psychiatric Comorbidities Among Patients Newly Diagnosed With Alopecia Areata

Abstract Full Text
open access
JAMA Dermatol. 2024;160(9):945-952. doi:10.1001/jamadermatol.2024.2404

This cohort study evaluates the prevalence, incidence, and risk of new-onset autoimmune and psychiatric comorbidities after alopecia areata diagnosis in adolescent and adult patients.

Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis: The GUIDE Randomized Clinical Trial

Abstract Full Text
open access
JAMA Dermatol. 2024;160(9):953-963. doi:10.1001/jamadermatol.2024.2463

This randomized clinical trial examines guselkumab dosing every 16 weeks vs standard dosing every 8 weeks for maintenance of psoriasis disease control by Psoriasis Area and Severity Index score in super responders.

Exploring the Germline Genetics of In Situ and Invasive Cutaneous Melanoma: A Genome-Wide Association Study Meta-Analysis

Abstract Full Text
JAMA Dermatol. 2024;160(9):964-971. doi:10.1001/jamadermatol.2024.2601

This genome-wide association study meta-analysis evaluates whether differences in risk of in situ melanoma and invasive melanoma are heritable.

Brief Report

Single-Lesion Skin Cancer Risk Stratification Triage Pathway

Abstract Full Text
has audio
JAMA Dermatol. 2024;160(9):972-976. doi:10.1001/jamadermatol.2024.1832

This cohort study examines the association of a rule-based triage system with skin cancer risk stratification of patients and wait times.

Sexual Orientation and Lifetime Prevalence of Skin Cancer Across Racial and Ethnic Groups

Abstract Full Text
JAMA Dermatol. 2024;160(9):977-983. doi:10.1001/jamadermatol.2024.2097

This cross-sectional study examines differences in lifetime prevalence of skin cancer across racial and ethnic groups by sexual orientation among US adults.

Area Deprivation and Disease Severity in Adult Patients With Discoid Lupus Erythematosus

Abstract Full Text
JAMA Dermatol. 2024;160(9):984-988. doi:10.1001/jamadermatol.2024.2355

This cross-sectional study examines the association between US Census block measures of deprivation and disease severity in adult patients with discoid lupus erythematosus.

Consensus Statement

Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCC

Abstract Full Text
has active quiz has audio
JAMA Dermatol. 2024;160(9):989-992. doi:10.1001/jamadermatol.2024.2242

This Consensus Statement develops recommendations for reporting measures and types of statistical analyses to be used in retrospective observational studies of cutaneous squamous cell carcinoma.

Images in Dermatology

Sodium-Dependent Multivitamin Transporter Deficiency

Abstract Full Text
has active quiz
JAMA Dermatol. 2024;160(9):993-994. doi:10.1001/jamadermatol.2024.1845

This case report describes a 3-year-old girl who presented with progressive pruritic, palmoplantar plaques, and periorifical exudative erythema who experienced hair loss, recurrent episodes of pneumonia, and transient thrombocytopenia.

Primary Cutaneous Cryptococcosis

Abstract Full Text
has active quiz
JAMA Dermatol. 2024;160(9):995-996. doi:10.1001/jamadermatol.2024.1899

This case report describes a woman in her 70s presenting with primary cutaneous cryptococcosis.

JAMA Dermatology Clinicopathological Challenge

Solitary Acute Necrotic Scrotal Ulcer in a Young Patient

Abstract Full Text
has active quiz
JAMA Dermatol. 2024;160(9):997-998. doi:10.1001/jamadermatol.2024.1950

A healthy young male patient was referred to the department of dermatology for evaluation of a solitary painful scrotal ulceration that developed rapidly 48 hours before consultation. What is your diagnosis?

Exanthematous Eruption in a Patient With Known Chronic Graft-vs-Host Disease and Recent Measles Vaccination

Abstract Full Text
has active quiz
JAMA Dermatol. 2024;160(9):999-1000. doi:10.1001/jamadermatol.2024.2042

A man in his 40s with a history of allogeneic stem cell transplant for diffuse large B-cell lymphoma and Graft-vs-host disease (GVHD) presented with a generalized eruption 1 week after receiving a measles, mumps, and rubella vaccination. What is your diagnosis?

JAMA Dermatology Patient Page

Bed Bugs

Abstract Full Text
free access
JAMA Dermatol. 2024;160(9):1015. doi:10.1001/jamadermatol.2024.0099

This Patient Page describes the symptoms, diagnosis, and treatment of bed bugs.

Research Letter

Upadacitinib for Treatment of Granulomatous Cheilitis

Abstract Full Text
open access
JAMA Dermatol. 2024;160(9):1001-1003. doi:10.1001/jamadermatol.2024.2378

This case series examines the effectiveness of the Janus kinase inhibitor upadacitinib for the treatment of granulomatous cheilitis.

Frequency of Skin Biopsies for Psoriasis by Race and Ethnicity

Abstract Full Text
JAMA Dermatol. 2024;160(9):1003-1005. doi:10.1001/jamadermatol.2024.2554

This cross-sectional study evaluates the frequency of skin biopsies, as an indicator of diagnostic uncertainty, by race and ethnicity among patients with psoriasis seen in an academic dermatology practice.

Characteristics of Hispanic Patients With Dermatomyositis

Abstract Full Text
JAMA Dermatol. 2024;160(9):1006-1007. doi:10.1001/jamadermatol.2024.2623

This cohort study compares the clinical features and outcomes of dermatomyositis between Hispanic and non-Hispanic patients.

Observation

Favorable Response to Type 2 Inhibitors in Patients With Darier Disease

Abstract Full Text
JAMA Dermatol. 2024;160(9):1007-1009. doi:10.1001/jamadermatol.2024.2298

This case report describes 2 female patients who both presented with severe and recalcitrant Darier disease who were treated with type 2 inflammation inhibitors.

Rapid Improvement in Refractory Acute Generalized Exanthematous Pustulosis With Spesolimab

Abstract Full Text
JAMA Dermatol. 2024;160(9):1009-1012. doi:10.1001/jamadermatol.2024.2311

This case report describes a woman in her 50s with rapid improvement in acute generalized exanthematous pustulosis symptoms after treatment with spesolimab.

Correction

Error in Table Footnote

Abstract Full Text
free access
JAMA Dermatol. 2024;160(9):1012. doi:10.1001/jamadermatol.2024.2673

Error in Studies Included

Abstract Full Text
free access
JAMA Dermatol. 2024;160(9):1012. doi:10.1001/jamadermatol.2024.3600
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2024;160(9):911. doi:10.1001/jamadermatol.2023.4000
×